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ABSTRACT 
Manganese (Mn) is a natural trace metal that is es- 
sential for many physiological functions in the human 
body. Astrocytes in the central nervous system are su- 
sceptible reservoirs for Mn accumulation. Estrogen, a 
steroidal hormone, has been shown to mitigate Mn- 
induced toxicity in cultures of postnatal astrocytes. 
However, differences in expression/inducibility of glu- 
tamate transporters and glutamine synthetase, trans- 
mitters, and the natural gonadal steroids and their re- 
ceptors are known to occur in astrocyte cultures de- 
rived from various stages of fetal and postnatal deve- 
lopment. Cultures of embryonic (E18) hippocampal 
astrocytes were examined in this study for the ability 
of 17 β-estradiol (E2) to protect them from Mn toxic- 
ity by up regulating gene expression of a glutamate 
transporter. Primary rat hippocampal astrocytes were 
pretreated with β-Estradiol (E2) in vitro and subse- 
quently, Mn sulfate (MnSO4). The amount of toxic 
damage to the astrocytes was measured by quantify- 
ing glial fibrillary acidic protein (GFAP) with a sand- 
wiched Enzyme-Linked Immunosorbent Assay (ELISA). 
ELISA analysis indicated Mn exposure at 100 μM, 
300 μM, or 600 μM significantly increased GFAP lev- 
els. However, E2 concentrations at 10 nM or 30 nM 
significantly reduced Mn-induced GFAP concentra- 
tions at 100 μM. Cells pretreated with 10 nM or 30 
nM of E2 significantly lowered GFAP levels. The Wa- 
ter-Soluble Tetrazolium-8 (WST-8) method was util- 
ized to determine cell viability. The WST-8 assay show- 
ed that Mn concentrations of 100 μM, 300 μM, or 600 
μM significantly reduced the dehydrogenase activity, 
thereby decreasing the number of viable astrocytes. 
Enzyme activity with 600 μM of Mn was significantly 
decreased when compared with 100 μM of Mn, re- 
vealing a dose-dependent effect. However, the dehy- 
drogenase activity in cells treated with 600 μM Mn 
was significantly increased when pretreated with 10 
nM of E2. Reverse Transcriptase-Polymerase Chain 
Reaction (RT-PCR) was used to measure changes in 
glutamate transporter-1 gene expression in astrocytes 
after pretreatment of E2 and subsequently, Mn. PCR 
analysis showed that when cells were exposed to 300 
μM Mn, the GLT-1 gene expression was reduced com- 
pared to the control. Data also showed that the GLT- 
1 mRNA was upregulated in cells pretreated with 10 
nM E2. When the cells were pretreated with 10 nM 
E2 and subsequently, 300 μM Mn, there was an in- 
crease in the GLT-1 gene expression. The experimen- 
tal results indicate that E2 can attenuate some Mn-in- 
duced toxicity in E18 astrocytes. 
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1. INTRODUCTION 
Astrocytes are brain cells believed to be adversely af- 
fected early by manganese (Mn) toxicity [1,2]. Although 
astrocytes perform numerous functions essential for 
brain activity, they accumulate up to 50 times higher Mn 
concentration compared to neurons [3,4]. The normal in- 
tracellular Mn concentrations are between 50 to 75 µM, 
serving as a cofactor for glutamine synthetase [3,5]. The 
buildup of excessive Mn within astrocytes is argued to 
mediate neurotoxicity by oxidative stress and diminish- 
ing glutamate transport [6,7]. In fact, Mn has been report- 
ed to down regulate gene expression of glutamate transpor- 
ters [8]. Estrogen (E) receptor agonists have even been re- 
ported to protect astrocytes from Mn-provoked neuroto- 
xicity by up regulating the gene expression of glutamate 
transporters [9-11]. In addition, Mn alters the glutamate- 
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glutamine homeostasis [12,13]. 
The above studies were conducted with postnatal as- 
trocytes. However, differences in expression/inducibi- 
lity of glutamate transporters and glutamine synthetase 
are known to occur in astrocyte cultures derived from va- 
rious stages of fetal and postnatal development [14,15]. 
Differences exist in transmitter effects on embryonic and 
postnatal astrocytes [16,17]. In addition, the natural go- 
nadal steroids and their receptors vary during fetal and 
postnatal development [18,19]. Cultures of embryonic 
(E18) hippocampal astrocytes were examined in this stu- 
dy for the ability of 17 β-estradiol (E2) to protect them 
from Mn toxicity by up regulating gene expression of a 
glutamate transporter. 
2. MATERIALS AND METHODS 
2.1. Cell Culture 
Primary Embryonic (day 18 Sprague/Dawley) rat hippo- 
campal astrocytes obtained from Gelantis (San Diego, 
CA) were prepared using the NeuroPapain enzyme. Fol- 
lowing enzymatic pretreatment, the supernatant (contain- 
ing the NeuroPapain solution) was removed, and the as- 
trocytes were placed in a 75 cm2 Poly-D-Lysine filter cap 
flask containing a complete media mixture of 34% Gibco 
DMEM High Glucose, 34% HyClone DME/High Glu- 
cose (1X), 25% HANKS, 3.5% Gibco Dialyzed Fetal 
Bovine Serum, and 3.5% HyClone Donor Equine Serum 
at 37˚C with 5% CO2. 
2.2. Trypsinization and Pretreatment  
Once cells reached 70% or greater confluence, 0.25% 
trypsin was used to remove them from the flask. After a 
wash with complete media, the astrocytes were transfer- 
red to a Poly-D-Lysine coated 48-well plate. The wells 
containing astrocytes and complete media mixture were 
treated with media or increasing concentrations of E2 on 
the same day. Twenty-four hours later, some of the wells 
were treated with increasing dosages of MnSO4. 
2.3. Bicinchoninic Acid (BCA) Assay 
Pierce BCA protein assay (Rockford, IL) was used to 
measure the level of total protein concentration present 
in the cell samples. The absorbance was read at 562 nm. 
2.4. Cell Viability Assay 
Cell viability was determined by measuring a water so- 
luble formazan after the addition of highly water soluble 
tetrazolium salts called WST-8. Cell Counting Kit-8 
(CCK-8, Sigma Chemical) used WST-8 to measure the 
dehydrogenase enzyme activity inside the cell to analyze 
the viability of the astrocytes. The absorbance was read 
at 450 nm. 
2.4. Enzyme-Linked Immunosorbent 
Assay (ELISA) 
The amount of toxicity damage to the astrocytes was 
measured by quantifying GFAP in a sandwiched ELISA, 
according to O’Callaghan [20]. A 96-well microtiter plate 
was coated with 100 μl of polyclonal rabbit anti-cow 
GFAP antibody, then incubated for 1 hr at 37˚C with 5% 
CO2 and overnight at 4˚C in the refrigerator. The poly- 
clonal anti-GFAP solution was washed with 200 μl of 
PBS four times. Next, 100 μl of BLOTTO (Bovine Lacto 
Transfer Technique Optimizer) was added and incubated 
for 1 hr. BLOTTO was removed and the purified GFAP 
standards and cell samples were loaded. The plate was 
washed four times with PBS and 0.5% Triton X-100 
combination. A solution of monoclonal anti-GFAP mouse 
antibody was mixed with BLOTTO and 0.5% Triton X- 
100 to be loaded and incubated for 1 hr at room tem- 
perature. Again, the plate was washed four times with the 
PBS and 0.5% Triton X-100 mixture. Alkaline Phospha- 
tase-Conjugated anti-mouse IgG was mixed with 
BLOTTO and 0.5% Triton X-100, added, and incubated 
for 30 mins at room temperature. The plate was washed 
four times with the PBS and 0.5% Triton X-100 mixture. 
P-Nitrophenyl Phosphate Liquid Substrate was added to 
the plate and incubated for 25 min at room temperature. 
Finally, 0.4 N NaOH was used to stop the reaction and 
the absorbance values were read at 405 nm. 
2.5. Reverse Transcriptase-Polymerase Chain  
Reaction (RT-PCR) 
RT-PCR was used to measure Glutamate Transporter-1 
gene expressions by detecting the levels of RNA in astro- 
cytes. Each sample was normalized to Glyceraldehyde 3- 
phosphate dehydrogenase (GAPDH) [21]. RNeasy Mini 
Kit from Qiagen was used to extract RNA from the as- 
trocytes by following the manufacture’s protocol. A 
High-Capacity cDNA Reverse Transcription Kit (Life Te- 
chnologies) was used to transcribe the RNA into a cDNA 
by following the manufacturer’s protocol. The first cycle 
was ran for 10 min at 25˚C, then 120 min at 37˚C, and 
finally, for 5 min at 85˚C. PCR was carried out using a 
Platinum PCR SuperMix (Life Technologies) by follow- 
ing the manufacturer’s protocol also. Primer sequences 
were: 5’-CCT CAT GAG GAT GCT GAA GA-3’ (GLT-1 
forward), 5’-TCC AGG AAG GCA TCC AGG CTG-3’ 
(GLT-1 reverse), 5’-TCC CTC AAG ATT GTC AGC 
AA-3’ (GAPDH forward), and 5’-AGA TCC ACA ACG 
GAT ACA TT-3’ (GAPDH reverse). Each primer was di- 
luted to 0.2 μM with RNase-free water according to the 
Certificate of Analysis. Then, the mixture was added to 
45 μl of PCR SuperMix to make up a total reaction vo- 
lume of 50 μl. Amplification was performed with 30 cy- 
cles at 94˚C for 30 s (denaturation), 55˚C for 30 s (an- 
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neal), and 72˚C for 1 min (extension). The samples were 
analyzed on a 1.5% agarose gel electrophoresis and vi- 
sualized by using GelRed Nucleic Acid Stain. 
2.5. Statistical Analysis 
Data was analyzed using One-way Analysis of Variance 
(ANOVA) using GraphPad Prism 5 Software with Dun- 
can’s new multiple range test [22]. P-values less than 
0.05 were considered significant. The number of primer 
sequence base pairs used in RT-PCR was analyzed from 
National Center for Biotechnology Information (NCBI) 
online @ http://www.ncbi.nlm.nih.gov/. The average pi- 
xel density (APD) of the agarose gel images was analy- 
zed using Image J64 to calculate the GLT-1/GAPDH per- 
centiles. 
3. RESULTS 
3.1. E2 Decreases GFAP Levels 
To determine the neuroprotective effects of E2, cells 
were pretreated with E2 for 72 hrs. The ELISA showed 
that astrocytes pretreated with E2 at 10 nM (p < 0.05) or 
30 nM (p < 0.05) significantly lowered GFAP levels when 
compared with the control (Figure 1). 
3.2. GFAP Levels Compared in Cells Treated  
with Mn and Cells with E2 and Mn 
To determine Mn’s toxic effect in astrocytes, the cells were 
treated with Mn for 48 hrs. The ELISA results showed 
that Mn significantly increased GFAP production (100 µM, 
p < 0.05; 300 µM, p < 0.05; 600 µM, p < 0.05) when 
compared to the control (Figure 2). Results also showed 
cells pretreated with 10 nM (p < 0.01) or 30 nM (p < 0.01) 
of E2 significantly lowered Mn-induced GFAP level at 
100 µM (Figure 2). 
3.3. E2 Effect on Dehydrogenase Activity  
Although not statistically significant, the WST-8 assay 
showed cells pretreated with E2 had a trend of increasing 
dehydrogenase activity starting at 10 nM (Figure 3). 
3.4. Dehydrogenase Activity Compared in Cells 
Treated with Mn and Cells Treated with E2 
and Mn 
The WST-8 assay showed that Mn significantly reduces 
the activity of dehydrogenase enzyme at 100 µM (p < 
0.01), 300 µM (p < 0.01), or 600 µM (p < 0.01) (Figure 
4). Data also show that the control is significantly diffe- 
rent from all treatment groups (p < 0.01) (Figure 4). The 
dehydrogenase activity in cells treated with 600 µM Mn 
was significantly increased when pretreated with 10 nM 
E2 (p < 0.05) (Figure 4). Enzyme activity with 600 
 
Figure 1. E2 effect on GFAP level using ELISA. Cells pre- 
treated with E2 at 10 nM (p < 0.05) or 30 nM (p < 0.05) sig- 
nificantly lowered GFAP levels when compared with the con- 
trol (n = 6). 
 
µM Mn was significantly decreased when compared with 
100 µM Mn (p < 0.05), revealing a dose-dependent effect 
(Figure 4). 
3.5. RT-PCR Results for Cells Treated with 10  
nM E2 and Cells with 10 nM E2 and 300  
μM Mn 
Gel electrophoresis and NCBI analysis showed PCR am- 
plified a portion of the GLT-1 gene that was 217 base 
pairs and 268 base pairs of the GAPDH gene (Figure 
5(a)). Although not statistically significant (n = 2), re- 
sults showed an increased expression of GLT-1 mRNA 
by 17% when cells were pretreated with 10 nM E2 (Fig- 
ure 5(b)). When cells were pretreated with 10 nM E2 
and afterward, exposed to 300 µM Mn, there was an in- 
creased production of the GLT-1 gene expression by 
12% (Figure 5(b)). 
4. DISCUSSION 
The present study demonstrates that acute exposure to E2 
can mitigate some Mn-induced toxicity in E18 astrocytes 
concerning inflammation, cell viability, and glutamate 
transport system. Mn was shown to induce toxicity and 
upregulate inflammation in astrocytes by significantly in- 
creasing GFAP production at 100 µM, 300 µM, or 600 
µM (Figure 2). Although not statistically significant, the 
GFAP levels trended to increase with the Mn concentra- 
tion. However, E2 concentrations at 10 nM or 30 nM sig- 
nificantly decreased Mn-induced GFAP concentrations at 
100 µM (Figure 2). In addition, E2 pretreated cells at 10 
nM or 30 nM significantly lowered GFAP levels compar- 
ed to the control (Figure 1). E2 could be reversing or in- 
hibiting the Mn-induced GFAP level. Rozovsky et al. [23] 
demonstrated the attenuation of GFAP via E2 in cortex 
astrocytes (1 - 3 day old) from ovariectomized female rats 
3 months old. It was also shown that the interaction of 
ERα and estrogen response element (ERE) were involved  
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Figure 2. GFAP levels compared in cells treated with Mn and cells treated with E2 and Mn. 
Mn was shown to significantly increase GFAP levels at 100 µM (p < 0.05), 300 µM (p < 0.05), 
or 600 µM (p < 0.05) when compared to the control (n = 6). However, cells pretreated with 10 
nM (p < 0.01) or 30 nM (p < 0.01) of E2 significantly lowered Mn-induced GFAP level at 100 
µM (n = 6). 
 
 
Figure 3. E2 effect on dehydrogenase activity using 
the WST-8 assay Dehydrogenase activity in cells. Cells 
pretreated with E2 were not statistically significant, 
but did show a tendency of increasing activity with 10 
nM and 30 nM (n = 6). 
 
in the gene expression of GFAP [23]. 
Cell viability depends on many chemicals and enzy- 
mes working together to ensure that biochemical reac- 
tions properly take place. Dehydrogenase enzyme is one 
that catalyzes the transfer of a hydride ion to nicotina- 
mide adenine dinucleotide (NAD) or nicotinamide ade- 
nine dinucleotide phosphate (NADP) in the mitochondria. 
These reactions are particularly important in glycolysis, 
citric acid cycle, and electron transport chain. Therefore, 
to determine the level of dehydrogenase activity would 
reveal the cell’s viability [24]. The WST-8 assay establi- 
shed that all treatment groups pretreated with E2 and/or 
exposed to Mn significantly affected the dehydrogenase 
activity in astrocytes when compared to the control 
(Figure 4). This could be due to the age of astrocytes 
employed; embryonic astrocytes could be especially sen-  
sitive to chemical agents, thus greatly affecting their cell 
viability [25]. Mn was shown to significantly reduce the 
enzyme’s activity at 100 µM, 300 µM, or 600 µM, there- 
by, significantly decreasing the number of viable astrocy- 
tes (Figure 4). Once excess Mn has been sequestered in 
the mitochondria, it could generate reactive oxygen spe- 
cies (ROS) generation, oxidative stress, and ultimately, 
apoptosis. Pretreatment of E2 at 10 nM was shown to 
significantly attenuate Mn-induced decrease in dehydro- 
genase activity at 600 µM (Figure 4). E2 was able to 
inhibit ROS and oxidative stress formation stimulated by 
Mn. Astrocyte protection afforded by E2 was most likely 
mediated through the activation of PI3K/ PKB/Akt and 
MAPK signaling pathways. Both pathways are exten- 
sively involved in Mn-induced cell death and neuro- 
protective effects of E2 [21,26]. Lee et al. (2009) con- 
ducted a similar experiment where they demonstrated 
Mn-induced cell death in neonatal rat primary astrocytes 
by generation of ROS [27]. The WST-8 assay showed 
cells pretreated with E2 had a non-significant increase in 
dehydrogenase activity starting at 10 nM (Figure 3). Also, 
Mn produces a dose-dependent effect when the dehydro- 
genase activity was significantly decreased at exposure 
to 600 µM vs. 100 µM (Figure 4). This result leads to 
the notion that the magnitude of adverse biological re- 
sponse in astrocytes caused by Mn is dependent on its 
concentration. 
Researchers have previously shown that E2 can in- 
crease the GLT-1 gene expression in cultures with rat ne- 
onatal midbrain and cortical astrocytes [27,28]. One of 
the experimental aims was to examine if the outcome 
would be similar in rat embryonic hippocampal astro- 
cytes. PCR analysis did show that the GLT-1 gene expre- 
ssion was upregulated in cells pretreated with 10 nM E2 
(Figure 5(b)). Due to the fact that an antagonist is not 
present, this could suggest that there was a slow genomic 
mechanism with E2 binding t  either ERα or β in the nu-  o  
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Figure 4. Dehydrogenase activity compared in cells treated with Mn and cells treated with E2 and Mn 
using WST-8 assay. Mn was shown to significantly reduce the enzyme’s activity at 100 µM (p < 0.01), 
300 µM (p < 0.01), or 600 µM (p < 0.01), thereby, significantly decreasing the number of viable as- 
trocytes (n = 6). The control group was shown to be significantly different from all treatment groups (p 
< 0.01) (n = 6). Pretreatment of E2 at 10 nM was shown to significantly decrease Mn-induced dehydro- 
genase activity at 600 µM (n = 6). Mn produced a dose-dependent effect when the dehydrogenase ac- 






Figure 5. GLT-1 levels in cells pretreated with 10 nM 
E2 compared with cells pretreated with 10 nM E2 and 
subsequently exposed to 300 μM Mn. Lanes 1, 3, and 5 
contain GLT-1 gene. Lanes 2, 4, and 6 contain GAPDH 
gene. PCR amplified a section of the GLT-1 gene that 
was 217 bp and 268 bp of the GAPDH gene. (a): Image 
J64 analysis showed pretreatment of E2 alone increased 
GLT-1 mRNA level by 17%; (b): When cells were pre- 
treated with 10 nM E2 and afterward, exposed to 300 
µM Mn, there was an increased production of the GLT- 
1 gene expression by 12%. 
 
cleus to activate ERE and acquire transcription of the 
GLT-1 gene. Another genomic possibility is via GPER 
and CRE transcription mechanisms [29]. To determine 
which ER contributes to the increased GLT-1 gene, ex- 
periments pertaining to the silencing of ERs by siRNA 
transfection could be carried out. For example, a knock- 
down of the GPER and then, treating astrocytes in cul- 
ture with G-1, a GPER agonist, could explain the role 
GPER plays. Through the process of elimination, it could 
deduce which ER is solely responsible or perhaps, it is 
the combination of 1 - 3 ERs [21]. 
However, with the upregulation of GLT-1 with 10 nM 
E2 and 300 μM Mn together (Figure 5(b)), there may be 
a more rapid mechanism to reverse Mn-induced decrease 
in the GLT-1 mRNA. It has been suggested that trans- 
forming growth factor-α (TGF-α) and multiple signaling 
pathways, which can include PI3K, MAPK, EGFR, and 
PKA, mediate the protective effects of E2 on Mn-induc- 
ed glutamate transport systems. The possibility that E2 
could be activating multiple signaling pathways simulta- 
neously to ensure cell proliferation and survival should 
be considered strongly. TGF-α, which mainly acts on as- 
trocytes and is upregulated by E2, is possibly a major 
component in the protection against the downregulation 
of GLT-1 gene expression. TGF-α would bind to its re- 
ceptor, EGFR, to activate the PI3K and MAPK signaling 
cascades, which would reverse or protect Mn-induced 
effect on GLT-1 proteins [30]. The notion that E2 could 
be mediating genomic effects in addition to non-genomic 
is also likely. When the cells were pretreated with E2 and 
Mn, E2 not only compensated for the loss of GLT-1 
mRNA caused by Mn, but it could have “overcorrected” 
the situation. It was observed that there was about a 12% 
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increase in the gene expression compared to the control 
group (Figure 5(b)). This protective mechanism against 
Mn would ensure increased glutamate uptake from the 
synaptic cleft and prevent neuroexcitation. 
The above evidence supports the hypothesis that E2 
can attenuate some Mn-induced toxicity in E18 astrocy- 
tes. The study revealed Mn’s degree of neurotoxic effects 
on astrocytes with varying concentrations. Mn level can 
exceed 350 μM in the brain during toxicity, but this study 
indicates a concentration starting at 100 μM can become 
dangerous for astrocytes [31]. This finding is pertinent to 
the growing concern of the association between delete- 
rious effects of excess Mn on astrocytes and develop- 
mental neurotoxicology. The Mn-induced levels of GFAP, 
dehydrogenase activity, and GLT-1 could be the bridge 
that connects this association. The results of this study 
indicate that E2 can shield rat fetal astrocytes from some 
of the cellular damage brought upon by Mn from day 18 
on, but the vulnerability of younger fetal astrocytes to 
Mn and possible E2 protection are unknown. 
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